140 related articles for article (PubMed ID: 34586488)
21. miR-519d-3p Overexpression Inhibits P38 and PI3K/AKT Pathway via Targeting VEGFA to Attenuate the Malignant Biological Behavior of Non-Small Cell Lung Cancer.
Zhang G; Hu Y; Yuan W; Qiu H; Yu H; Du J
Onco Targets Ther; 2020; 13():10257-10266. PubMed ID: 33116606
[TBL] [Abstract][Full Text] [Related]
22. miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non-Small Cell Lung Cancer Cells by Targeting USP37.
Kim MS; Kim SH; Yang SH; Kim MS
Cancer Res Treat; 2022 Apr; 54(2):445-457. PubMed ID: 34352998
[TBL] [Abstract][Full Text] [Related]
23. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
Jin S; He J; Li J; Guo R; Shu Y; Liu P
Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
[TBL] [Abstract][Full Text] [Related]
24. miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC.
Feng QQ; Dong ZQ; Zhou Y; Zhang H; Long C
Bratisl Lek Listy; 2018; 119(1):60-65. PubMed ID: 29405733
[TBL] [Abstract][Full Text] [Related]
25. SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p.
Wu K; Li J; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
Biomed Pharmacother; 2019 Aug; 116():108995. PubMed ID: 31121484
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
29. Impact of miR-519d on the Biological Activity of Non-Small Cell Lung Cancer Cells and Its Mechanism.
Wang K; Zhao X; Liu S; Xu S
Altern Ther Health Med; 2024 Jan; 30(1):466-471. PubMed ID: 37820678
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
31. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
[TBL] [Abstract][Full Text] [Related]
32. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
Hu C; Zou Y; Jing LL
J Biosci; 2020; 45():. PubMed ID: 32345774
[TBL] [Abstract][Full Text] [Related]
33. MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer.
Wang A; Zhang H; Wang J; Zhang S; Xu Z
Aging (Albany NY); 2020 Mar; 12(6):4866-4878. PubMed ID: 32170048
[TBL] [Abstract][Full Text] [Related]
34. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways.
Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X
Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688
[TBL] [Abstract][Full Text] [Related]
35. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
36. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy.
Zhang W; Dong YZ; Du X; Peng XN; Shen QM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2444-2452. PubMed ID: 30964170
[TBL] [Abstract][Full Text] [Related]
37. MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines.
Zhou YM; Liu J; Sun W
Asian Pac J Cancer Prev; 2014; 15(3):1391-6. PubMed ID: 24606471
[TBL] [Abstract][Full Text] [Related]
38. Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis.
Yu X; Fu X; Zhang X; Bai C; Wang Y
Anticancer Drugs; 2022 Feb; 33(2):158-166. PubMed ID: 34694278
[TBL] [Abstract][Full Text] [Related]
39. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
40. LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis.
Wen H; Feng H; Ma Q; Liang C
BMC Pulm Med; 2021 Jul; 21(1):234. PubMed ID: 34261474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
